First-Ever Peer-Reviewed Study of Vaccinated vs

New Post Public Reply Private Reply Replies (1) Message Board
wowhappens28 Bhawks #19204
330
First-Ever Peer-Reviewed Study of Vaccinated vs Unvaccinated Children Shows Vaccinated Kids Have a Higher Rate of Sickness, 470% Increase in Autism

May 7, 2017 Mark Blaxill, Age of Autism Health 41

https://needtoknow.news/2017/05/first-ever-pe...se-autism/

The first-ever, peer-review study has been published comparing total-health in vaccinated and unvaccinated children. Dr. Anthony Mawson led a research team that investigated the relationship between vaccination exposures and acute or chronic illnesses in home-schooled children. The vaccinated children had a much higher rate of autism and ADHD, at a rate of 470% higher than those who received no shots. Vaccinated children were also more vulnerable to allergies and eczema. Unvaccinated children contract mild childhood diseases more frequently, but their vaccinated counterparts suffer pneumonia and ear infections more frequently. The finding that vaccination introduces a significant risk for autism is devastating to the vaccine industry and, therefore, will be vigorously attacked. –GEG
Pilot Comparative Study on the Health of Vaccinated and Unvaccinated 6-12 Year Old US Children
In a development that autism parents have long anticipated, the first-ever, peer-reviewed study comparing total health outcomes in vaccinated and unvaccinated children was released on line yesterday. According to sources close to the project, the study had been reviewed and accepted by two different journals, both of which pulled back on their approval once the political implications of the findings became clear. That’s largely because, as parents have long expected, the rate of autism is significantly higher in the vaccinated group, a finding that could shake vaccine safety claims just as the first president who has ever stated a belief in a link between vaccines and autism has taken office.

Working in partnership with the National Home Education Research Institute (NHERI), Dr. Anthony Mawson led a research team that investigated the relationship between vaccination exposures and a range of over 40 acute and chronic illnesses in home schooled children, a population chosen for its high proportion of unvaccinated children. Surveying families in four states–Florida, Louisiana, Mississippi and Oregon—the study (officially titled Vaccination and Health Outcomes: A Survey of 6- to 12-year-old Vaccinated and Unvaccinated Children based on Mothers’ Reports), reported a number of startling findings.

Vaccinated children were significantly more likely than the unvaccinated to have been diagnosed with a neurodevelopmental disorder: most notably, the risk of being affected by an Autism Spectrum Disorder (ASD) was 4.7 fold higher in vaccinated children; as well, ADHD risk was 4.7 fold higher and learning disability risk was 3.7 fold higher. Overall, the vaccinated children in the study were 3.7 times more likely to have been diagnosed with some kind of neurodevelopmental disorder.

Vaccinated children were also significantly more likely to be diagnosed with an immune-related disorder. The risk of allergic rhinitis (commonly known as hay fever) was over 30 times higher in vaccinated children, while the risk of other allergies was increased 3.9 fold and the eczema risk was increased 2.4 fold.

With respect to acute illness and infectious disease the outcomes were in some respects surprising. As might be expected, unvaccinated children were significantly (4-10 times) more likely to have come down with chicken pox, rubella or pertussis. Perhaps unexpectedly, the unvaccinated children were less likely to suffer from otitis media and pneumonia: vaccinated children had 3.8 times greater odds of a middle ear infection and 5.9 times greater odds of a bout with pneumonia.

The study was based on a survey with participants recruited in a process led by NHERI and coordinated through 84 state and local homeschool groups. The survey itself was, according to the authors, “nonbiased and neutrally worded.”

These findings in a study population of 666 children, 261 of whom (39%) were unvaccinated, are sure to stir controversy, in part because it is the first of its kind. The scientific literature on the long-term effects of the vaccination program is virtually silent. Most studies on the safety of vaccines only consider immediate or short-term effects. There was no obvious explanation for the differences in health outcomes observed between the vaccinated and unvaccinated groups of children other than vaccination itself.

The finding that vaccination is a significant risk for autism is the most explosive finding in the paper. For well over a decade, parents concerned that vaccines were involved in autism’s sharp rise have been calling for what has long been labelled the “vax/unvax” study. Public health officials such as Paul Offit have resisted these calls with claims that a comparative study of autism risk and other health outcomes in unvaccinated and vaccinated children would be retrospectively impossible and prospectively unethical.

Despite opposition from those like Offit, attempts to launch a formal vax/unvax study have been made for many years. In 2006, Congresswoman Carolyn Maloney (D, NY) authored what is now called Vaccine Safety Study Act. Said Maloney to the opponents, “Maybe someone in the medical establishment will show me why this study is a bad idea, but they haven’t done it yet.” In 2007, Generation Rescue (one of the Mawson study’s sponsors) retained a market research firm to undertake a similar survey (it is available on line and had similar findings but was never published in a scientific journal).

Less formal surveys focused on whether or not autism was present in the unvaccinated have also been undertaken in unusual populations, including the Amish and the patients of alternative health practitioners. Age of Autism founder Dan Olmsted investigated autism in the Amish, who vaccinate less frequently. Autism is rare among the Amish and the only autistic Amish children we discovered were also vaccinated. (Others reported cases in Amish children with birth defects, but not “idiopathic autism,” the kind that occurs in otherwise typical children who are the heart of the current epidemic). The late Mayer Eisenstein reported in his HomeFirst practice in Chicago that he delivered more than 15,000 babies at home, and thousands of them were never vaccinated. Of these unvaccinated children, none had autism.

The link between autism and vaccination became a hot topic in this year’s presidential election. Democratic candidate Hillary Clinton once tweeted ““The science is clear: The earth is round, the sky is blue, and #vaccineswork. Let’s protect all our kids. #GrandmothersKnowBest.” In contrast, President Donald Trump has long been outspoken about the likely connection between vaccines and autism. As early as 2007, Trump remarked, “When I was growing up, autism wasn’t really a factor. And now all of a sudden, it’s an epidemic. Everybody has their theory, and my theory is the shots. They’re getting these massive injections at one time. I think it’s the vaccinations.”

Read Full Article Here…
https://www.ageofautism.com/2017/05/pilot-com...ldren.html
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Melrose Fire Station Reaches Steel Topping Milestone

Updated Category News Views 4

Metal and Milestones: A New Era for Melrose Rolling into Melrose, Massachusetts, there's some serious action kicking off with the new Fire Engine 2 Station reaching a steel topping milestone. This phase isn't just about slapping on another beam; it's the crescendo of diligent teamwork from all the hands involved—from CTA Construction Managers to the clout of Ironworkers...

Continue Reading
Leo Cancer Care's Upright Radiotherapy Milestone

Updated Category News Views 4

Upright Radiotherapy: Breaking Tradition in Cancer Care Here's a twist in the world of cancer treatment folks weren't exactly expecting. Leo Cancer Care has flipped the script by taking radiotherapy from a concept to an actual clinical reality with their Upright Platform. Yes, we're talking about standing up while getting treated, and it's not just a gimmick—it's a game...

Continue Reading
Quay Shines in 2026 Prescription Sunglasses Lineup

Updated Category News Views 5

Spotlight on Quay: A Fashion-Forward Prescription Glasses that make you look good and actually correct your vision? That's the holy grail right there. Consumer365 just put Quay front and center in their 2026 rundown of the best prescription sunglasses out there. Let's break this down and see what's got folks buzzing. Diving into Style and Substance Now, if you're like me,...

Continue Reading
Synagro Technologies Faces Lawsuit Over Unpaid Expenses

Updated Category News Views 6

Another Day, Another Lawsuit in Corporate America When it rains, it pours, especially in the corporate world where companies occasionally seem to forget they're playing with other people's livelihoods. Now, it's Synagro Technologies, Inc. facing the music. The company is under fire from Blumenthal Nordrehaug Bhowmik De Blouw LLP, a law firm well-versed in employee rights...

Continue Reading
Revamping Children's Radiotherapy: Leo Cancer Care's Vision

Updated Category News Views 5

The latest buzz in pediatric radiotherapy is shaking things up, and it’s all thanks to a game-changing shift in how treatment is delivered to kids. We're eyeballing Leo Cancer Care's innovative approach that might just redefine how these young patients face their battles. Standing Tall: A New Chapter in Proton Therapy In June, Stanford Medicine dished out the first...

Continue Reading
IASO's FUCASO Shows Robust Results in 2026 Study

Updated Category News Views 6

IASO's Groundbreaking Results Stir Ripples in Oncology Folks, let me paint the picture here with the mighty, nitty-gritty details straight from the heart of China. The 2026 IMS Annual Meeting held a gem that could redefine how investors see the course of hematologic malignancy treatments. IASO Bio dropped some heavy data, showing their fine product, FUCASO, in a...

Continue Reading
Fuse Oncology Showcases New iRT Workflow at ASTRO

Updated Category News Views 4

Revolutionizing Charge Capture in Oncology Fuse Oncology's latest showcase at the ASTRO 2026 Annual Meeting isn't just about flashy presentations—it's looking to change how radiation oncology departments handle complex workflows. If you've ever delved into the maze of oncology billing, you know it's rife with opportunities for errors and inefficiencies. Skip one charge,...

Continue Reading
AI Memory Growth Pushes Limits at GMIF2026 Summit

Updated Category News Views 3

The Memory and Storage Race in the AI Era The 5th GMIF2026 Innovation Summit wrapped up in Shenzhen, and boy, was it a heavyweight bout. You could practically feel the tension in the room as industry giants sparred over the future of memory and storage in AI. This wasn't just another trade show pow-wow; this was a strategic chess match over where AI infrastructure is...

Continue Reading
Salveo Home Care Faces Class Action Over Labor Violations

Updated Category News Views 5

Another Company Lands in Hot Water Alright, it looks like Salveo Home Care is in the spotlight for all the wrong reasons. The home care provider—which should have been minding its P's and Q's—is now facing a class action suit. Why, you ask? Well, for allegedly skimping on wages and dodging legal obligations that leave their employees hanging dry. The Allegations are...

Continue Reading
DKS Facing Class Action Over Stock Slump Allegations

Updated Category News Views 3

A Burst Bubble at DICK'S Sporting Goods Grit your teeth and hang on—DICK'S Sporting Goods has stumbled, and investors are supposed to just weather the storm. From September 8, 2025, through August 24, 2026, if you held DICK'S shares, you've got some explaining to do, or at least you better start reading the fine print. Take note, folks: the deadline to file for lead...

Continue Reading

Top 5 Most Recently Viewed Articles

Celcuity Inc. Prepares for Third Quarter Financial Results

Updated Category News Views 91

Celcuity Inc. Announces Upcoming Financial Results Release Celcuity Inc. (NASDAQ: CELC), a pioneering biotechnology company focused on innovative oncology therapies, has exciting news. The company will be releasing its financial results for the third quarter of 2025 after the market closes. This significant event is scheduled for a Wednesday, with management set to...

Continue Reading
EverTrue and DonorSearch Team Up to Revolutionize Fundraising

Updated Category News Views 973

EverTrue's Strategic Acquisition of DonorSearch EverTrue, a leader in donor engagement and pipeline development, recently announced a significant acquisition. The company has acquired DonorSearch, known for its innovative AI-powered donor discovery solutions. This strategic move is aimed at enhancing the capabilities of fundraising teams, enabling them to connect with...

Continue Reading
Celebrating Creativity and Inclusion: ADCOLOR Awards 2025

Updated Category News Views 315

ADCOLOR Awards 2025: A Night of Inspiration and Celebration Presented by leading organizations in the industry like Amazon, Disney, and Meta, the ADCOLOR Awards is a prestigious event celebrating remarkable individuals and organizations that champion diversity and inclusion in creative fields. This year's ceremony showcased inspiring figures such as Richelieu Dennis,...

Continue Reading
Transforming a $1000 Investment in First Solar to $3700

Updated Category News Views 161

Transform Your Investment with First Solar First Solar (NASDAQ: FSLR) has shown impressive performance over the past decade. This company has not only managed to keep pace with the market but has actually outperformed it by an average of 2.49% annually. This impressive annualized return translates to an average annual growth of 14.22%, making First Solar a notable player...

Continue Reading
Carpenter Technology Announces New Quarterly Dividend Plans

Updated Category News Views 107

Carpenter Technology Announces Quarterly Cash Dividend Carpenter Technology Corporation (NYSE: CRS), a leading name in high-performance specialty alloys, has made a significant announcement regarding its quarterly cash dividend. The company's Board of Directors has declared a dividend of $0.20 per share on common stock, underscoring its commitment to returning value to...

Continue Reading